Stimwave Technologies
Pompano Beach, US · Founded 2010 · Delaware corporation · 2 known investors
Founders & leadership
Stimwave Technologies was founded in 2010 by Laura Tyler Perryman.
LT
Laura Tyler PerrymanFounder
RG
Regina GrovesExecutive
VS
Virginia SullivanNamed on SEC filing
ML
Marc LoevNamed on SEC filing
RC
Richard Chen MaoNamed on SEC filing
GP
Gary PerrymanNamed on SEC filing
SS
Scott SidwellNamed on SEC filing
AB
Aure BruneauNamed on SEC filing
JG
Jeffrey GoldbergNamed on SEC filing
RG
Richard GumerNamed on SEC filing
LT
Laura T PerrymanNamed on SEC filing
RK
Robert K. AndersonNamed on SEC filing
Investors · 2
Reported raises · per SEC filings
Form D private placements$5.3M disclosed across 2 rounds · 2014–2020
▶$3.3MraisedSep 2020 · 15 investors · BiotechnologyRule 506(b)
▶$3.3MraisedSep 2020 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul LavioletteDirector
- Virginia SullivanExecutive Officer
- Marc LoevDirector
- Richard Chen MaoDirector
- Gary PerrymanDirector
- Scott SidwellExecutive Officer
- Laura Tyler PerrymanDirector
- Aure BruneauExecutive Officer
- Jeffrey GoldbergDirector
- Richard GumerDirector
- Regina GrovesExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $3.3M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedJul 2014 · 1 investors · Other Health CareRule 506(b)
▶$2MraisedJul 2014 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Gary PerrymanDirector
- Laura T PerrymanExecutive Officer, Director
- Robert K. AndersonDirector
- Offering amount
- $6M
- Amount sold
- $2M
- Minimum investment
- $1
- First sale
- Jul 2014
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 7
by search overlapSofwave5 shared keywordsSofwave develops non-invasive, FDA-cleared ultrasound and electrical muscle stimulation (EMS) devices for improving skin laxity, lift, and tone by stimulating natural collagen, elastin, and hyaluronic acid production. Its aesthetic technology products also strengthen and tone muscles.
Shockwave Medical4 shared keywordsShockwave Medical develops intravascular lithotripsy (IVL) catheter systems used to treat calcified cardiovascular disease, marketed to interventional cardiologists and vascular specialists. Its products are medical devices consisting of catheters paired with generators.
Biowave Corporation4 shared keywordsBioWave develops patented high-frequency neurostimulation devices that deliver therapeutic stimulation deep into the body to block pain signals at the nerve source, aimed at chronic pain patients and athletes. Its products are used in settings such as Veterans Affairs, orthopedic and pain health systems, and by professional sports trainers.
SecondWave Systems, Inc.4 shared keywordsSecondWave Systems develops a noninvasive, wearable ultrasound stimulation device that modulates nerves, cells, and organs deep in the body for at-home treatment of conditions such as inflammation and pain. The platform is aimed at patients and physicians as an alternative to medication-based therapies for debilitating or life-threatening diseases.
Stimlabs3 shared keywordsStimLabs develops regenerative medicine products, including its Corplex P device, used by physicians for wound healing and complex clinical cases. The company markets a portfolio of regenerative technologies for patient care.
Neuwave Medical3 shared keywordsNeuWave Medical develops the NeuWave Microwave Ablation System, a device used by healthcare professionals to ablate soft tissue, including non-resectable liver tumors, in percutaneous, open surgical, and laparoscopic settings. The system includes a probe portfolio and ABLATE-IQ software for margin confirmation, and is marketed for use in the United States; the company is a wholly owned subsidiary of Quantum Surgical, Inc.
Radwave Technologies3 shared keywordsRadWave Technologies builds an electromagnetic (EM) tracking platform, including radiolucent antennas and 5 & 6 DOF sensor sub-assemblies, for image-guided, minimally invasive, and robotic surgical navigation procedures. It supplies medical device manufacturers with customizable turnkey tracking solutions plus sensor integration and SDK/API development support.
Companies competing with Stimwave Technologies for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- Who founded Stimwave Technologies?
- Stimwave Technologies was founded by Laura Tyler Perryman in 2010.
- Who are Stimwave Technologies's investors?
- Stimwave Technologies's investors include Emergent Medical Partners, LLP, SV Health Investors.
- How much funding has Stimwave Technologies raised?
- Stimwave Technologies has disclosed $5.3M raised across 2 rounds.
- Where is Stimwave Technologies headquartered?
- Stimwave Technologies is headquartered in Pompano Beach, US.